Muscle MRI in Pompe

Pompe disease is a rare genetic disorder leading to progressive muscle weakness due to a glycogen storage defect, which currently lacks a non-invasive method for early detection and treatment monitoring. This study aims to address this critical need by employing a new MRI technique, Carbon Spectroscopy, which detects the Carbon present in the glycogen of the muscles and therefore allows us to measure glycogen levels in patients with Late-Onset Pompe Disease (LOPD). By tracking changes in muscle glycogen over time there is potential to improve the management of Pompe disease, leading to earlier intervention, improved treatment outcomes, and a better quality of life for patients.

Cookie consent

We use some essential cookies to make this website work.

We also use cookies set by other sites to help us deliver content from their services, like fonts and maps.

For more details, please see our Cookie Policy